WallStreetZenWallStreetZen

Stock ScreenerStock IdeasBiotech Breakthroughs
Best Biotech Stocks To Buy Now
Top biotech stocks that analysts expect to be profitable within the next 3 years

Industry: Biotechnology
Forecast Earnings Growth: Positive
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Consensus
Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
TECH
BIO-TECHNE CORP
$12.74B$81.19$290.50257.80%Strong Buy813.75%125.98%97.88%72.92%
BMRN
BIOMARIN PHARMACEUTICAL INC
$21.79B$117.27$113.83-2.93%Strong Buy1225.56%109.60%N/AN/A
ABCM
ABCAM PLC
$3.76B$16.43$20.0021.73%Hold220.18%77.19%16.77%11.46%
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$2.88B$48.57$63.6331.00%Strong Buy832.60%24.30%N/AN/A
GMAB
GENMAB A
$25.59B$38.87$38.35-1.35%Hold631.54%26.20%N/AN/A
HALO
HALOZYME THERAPEUTICS INC
$6.86B$50.71$60.7119.73%Strong Buy727.66%53.09%N/AN/A
CSBR
CHAMPIONS ONCOLOGY INC
$55.73M$4.11$15.00264.96%Strong Buy29.07%1,900.00%66.52%16.78%
NBIX
NEUROCRINE BIOSCIENCES INC
$10.41B$108.25$120.8111.61%Buy1618.99%129.37%N/AN/A
EXEL
EXELIXIS INC
$5.64B$17.47$26.8653.73%Buy715.08%28.14%N/AN/A
INCY
INCYTE CORP
$19.07B$85.70$75.83-11.51%Hold715.65%25.66%N/AN/A
RPRX
ROYALTY PHARMA PLC
$23.62B$38.90$52.6735.39%Strong Buy610.61%58.96%N/AN/A
XOMA
XOMA CORP
$238.75M$20.85$62.50199.76%Strong Buy315.00%42.57%N/AN/A
XRTX
XORTX THERAPEUTICS INC
$7.98M$0.61$17.502,750.16%Strong Buy1N/A101.95%N/AN/A
NVO
NOVO NORDISK A S
$312.30B$138.09N/AN/ABuy415.74%21.72%N/AN/A
VNDA
VANDA PHARMACEUTICALS INC
$432.91M$7.65$12.0056.86%Hold12.43%34.55%N/AN/A
PBYI
PUMA BIOTECHNOLOGY INC
$193.51M$4.24$8.0088.68%Buy13.93%44.35%N/AN/A
UTHR
UNITED THERAPEUTICS CORP
$11.84B$259.68$279.827.75%Buy1212.97%13.28%N/AN/A
ICPT
INTERCEPT PHARMACEUTICALS INC
$762.08M$18.40$23.6328.40%Buy831.78%5.70%N/AN/A
CPRX
CATALYST PHARMACEUTICALS INC
$1.62B$15.52$20.3831.28%Strong Buy412.14%14.45%N/AN/A
CORT
CORCEPT THERAPEUTICS INC
$2.50B$23.26$30.0028.98%Buy313.56%18.68%N/AN/A
VRTX
VERTEX PHARMACEUTICALS INC
$82.51B$321.45$322.140.22%Buy146.64%3.58%N/AN/A
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.